Title | Type | SJR | H index | Total Docs. (2004) | Total Docs. (3years) | Total Refs. (2004) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2004) | %Female (2004) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Cancer Chemotherapy and Pharmacology, Supplement | journal | 0.465 Q3 | 35 | 0 | 63 | 0 | 132 | 63 | 1.75 | 0.00 | 0.00 | |
52 | Journal of Cancer Epidemiology and Prevention | journal | 0.458 Q3 | 10 | 0 | 22 | 0 | 29 | 22 | 1.32 | 0.00 | 0.00 | |
53 | Journal of Biological Regulators and Homeostatic Agents | journal | 0.390 Q4 | 56 | 57 | 192 | 2099 | 190 | 178 | 0.98 | 36.82 | 42.71 | |
54 | In Vivo | journal | 0.341 | 72 | 110 | 274 | 4938 | 258 | 273 | 0.95 | 44.89 | 31.75 | |
55 | Oncology Research and Treatment | journal | 0.340 Q4 | 55 | 96 | 373 | 2622 | 332 | 325 | 0.92 | 27.31 | 18.77 | |
56 | European Journal of Cancer, Supplement | journal | 0.327 Q4 | 29 | 65 | 51 | 1626 | 27 | 50 | 0.53 | 25.02 | 18.18 | |
57 | Journal of Experimental and Clinical Cancer Research | journal | 0.322 Q4 | 120 | 92 | 349 | 2567 | 299 | 345 | 0.79 | 27.90 | 30.44 | |
58 | Tumori | journal | 0.270 Q4 | 59 | 146 | 768 | 3593 | 487 | 744 | 0.78 | 24.61 | 36.55 | |
59 | Journal of Brachytherapy International | journal | 0.240 Q4 | 12 | 0 | 33 | 0 | 14 | 32 | 0.00 | 0.00 | 0.00 | |
60 | IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer | book series | 0.216 Q4 | 50 | 17 | 29 | 2216 | 24 | 29 | 3.00 | 130.35 | 25.00 | |
61 | Prostate Journal | journal | 0.212 Q4 | 7 | 0 | 20 | 0 | 7 | 15 | 0.00 | 0.00 | 0.00 | |
62 | Bulletin du Cancer | journal | 0.201 Q4 | 44 | 192 | 573 | 5628 | 339 | 460 | 0.61 | 29.31 | 34.61 | |
63 | Women's Oncology Review | journal | 0.146 | 4 | 110 | 29 | 662 | 4 | 21 | 0.14 | 6.02 | 39.38 | |
64 | Gann Monographs on Cancer Research | book series | 0.142 Q4 | 10 | 41 | 46 | 1744 | 16 | 45 | 0.38 | 42.54 | 10.23 | |
65 | Cancer Research, Therapy and Control | journal | 0.133 Q4 | 13 | 0 | 36 | 0 | 7 | 36 | 0.00 | 0.00 | 0.00 | |
66 | Journal of B.U.ON. | journal | 0.119 Q4 | 37 | 81 | 227 | 2059 | 14 | 204 | 0.06 | 25.42 | 45.54 | |
67 | Clinical and Translational Oncology | journal | 0.117 Q4 | 61 | 100 | 259 | 2776 | 22 | 221 | 0.09 | 27.76 | 37.15 | |
68 | Journal of Tumor Marker Oncology | journal | 0.114 Q4 | 9 | 0 | 17 | 0 | 3 | 17 | 0.00 | 0.00 | 0.00 | |
69 | Breast Disease | journal | 0.110 Q4 | 36 | 33 | 90 | 1761 | 5 | 84 | 0.06 | 53.36 | 50.65 | |
70 | UroOncology | journal | 0.106 Q4 | 5 | 29 | 76 | 699 | 1 | 68 | 0.01 | 24.10 | 17.24 | |
71 | Electronic Journal of Oncology | journal | 0.102 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
72 | International Journal of Pediatric Hematology/Oncology | journal | 0.102 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
73 | Leukaemia Risks in Relation to Benzene Exposure | conference and proceedings | 0.102 | 1 | 0 | 9 | 0 | 1 | 9 | 0.11 | 0.00 | 0.00 | |
74 | Acta Oncologica, Supplement | journal | 8 | 6 | 0 | 107 | 0 | 0 | 0.00 | 17.83 | 25.00 | ||
75 | Cancer Communications | journal | 79 | 362 | 553 | 542 | 123 | 553 | 0.22 | 1.50 | 33.84 | ||
76 | Cancer Genomics and Proteomics | journal | 50 | 45 | 0 | 1962 | 0 | 0 | 0.00 | 43.60 | 32.24 | ||
77 | Cellular Oncology | journal | 44 | 29 | 0 | 782 | 0 | 0 | 0.00 | 26.97 | 37.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®